Fundación para la Investigación del Hospital Clínico de Valencia
incliva.esTotal trials
67
Active
18
Phase 3
3
Total enrollment
23,356
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dapagliflozin | — | — | — | — | — | 2 | |
| Ferric Carboxymaltose Injection [Ferinject] | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 1 | |
| Dulaglutide | — | — | — | — | — | 1 | |
| Semaglutide 1.0 mg | — | — | — | — | — | 1 | |
| Empagliflozin | — | — | — | — | — | 1 | |
| Canagliflozin | — | — | — | — | — | 1 | |
| pioglitazone | — | — | — | — | — | 1 | |
| Sitagliptin | — | — | — | — | — | 1 | |
| Vildagliptin | — | — | — | — | — | 1 | |
| linagliptin | — | — | — | — | — | 1 | |
| Sodium Zirconium Cyclosilicate | — | — | — | — | — | 2 | |
| Standard of care treatment | — | — | — | — | — | 1 |
Next readouts
- 2025-07-30
- 2025-12-01
- 2026-06-30
- 2026-12-30
- 2028-04
Top conditions
- Heart Failure8
- Gastric Cancer4
- Type 1 Diabetes3
- Breast Cancer3
- Lung Collapse3
- Heart Failure With Preserved Ejection Fraction2
- Chronotropic Incompetence2
- Magnetic Resonance2
Frequently asked questions about Fundación para la Investigación del Hospital Clínico de Valencia
- How many clinical trials does Fundación para la Investigación del Hospital Clínico de Valencia have on ClinicalTrials.gov?
- Fundación para la Investigación del Hospital Clínico de Valencia is listed as the lead sponsor on 67 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Fundación para la Investigación del Hospital Clínico de Valencia's trials are in Phase 3?
- 3 of Fundación para la Investigación del Hospital Clínico de Valencia's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Fundación para la Investigación del Hospital Clínico de Valencia focus on?
- Fundación para la Investigación del Hospital Clínico de Valencia's most-studied conditions on ClinicalTrials.gov are Heart Failure, Gastric Cancer, Type 1 Diabetes, Breast Cancer, Lung Collapse.
- When are Fundación para la Investigación del Hospital Clínico de Valencia's next clinical trial readouts?
- Fundación para la Investigación del Hospital Clínico de Valencia has 5 upcoming primary-completion readouts tracked here; the soonest is “Keeping RAASi Treatment With Optimal Potassium Control”, expected around 2025-07-30.